NASDAQ: BOLD
Boundless Bio Inc Stock Ownership - Who owns Boundless Bio?

Insider buying vs selling

Have Boundless Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BOLD insiders and whales buy or sell their stock.

BOLD Shareholders

What type of owners hold Boundless Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.96%3,125,103$4.28MInstitution
Nextech Invest Ltd5.49%1,228,069$1.68MInstitution
Keith Crandell5.28%1,181,766$1.62MInsider
Kristina Burow5.28%1,181,766$1.62MInsider
Arch Venture Fund IX LP5.28%1,181,766$1.62MInsider
Citadel Advisors LLC3.71%830,936$1.14MInstitution
Sectoral Asset Management Inc3.03%678,574$929.65kInstitution
Jonathan E. Lim2.92%653,479$895.27kInsider
Redmile Group LLC2.63%589,034$806.98kInstitution
Wellington Management Group LLP2.48%556,233$762.04kInstitution

1 of 3

BOLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLD43.72%23.82%
TENX21.85%78.15%
IMA75.44%24.56%Net BuyingNet Buying
LIMN0.76%85.86%
ITRM5.30%51.07%Net BuyingNet Buying

Boundless Bio Stock Ownership FAQ

Who owns Boundless Bio?

Boundless Bio (NASDAQ: BOLD) is owned by 43.72% institutional shareholders, 23.82% Boundless Bio insiders, and 32.46% retail investors. Keith Crandell is the largest individual Boundless Bio shareholder, owning 1.18M shares representing 5.28% of the company. Keith Crandell's Boundless Bio shares are currently valued at $1.62M.

If you're new to stock investing, here's how to buy Boundless Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.